Brand profile · Pharmaceutical Manufacturing

Douglas Pharmaceuticals

Douglas Pharmaceuticals is a Pharmaceutical Manufacturing brand in Auckland, AUK. Ownership is privately held; it publishes at douglas.co.nz. It holds one address on record, all in New Zealand. The record counts 616 people. Tagged r&d and pharma. Its latest round on record is Grant, US$76.4K. It is listed alongside ten similar brands, mostly in Pharmaceutical Manufacturing.

Profile live Privately Held Founded 1967 1 office country US$ 76.4K Grant

Key facts

Counted staff
616
self-reported 501–1,000 band
Founded
1967
59 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
4
Grant · Sep 2023 · US$ 76.4K
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Description

Douglas Pharmaceuticals is a New Zealand success story – a family-owned pharmaceutical company with a reputation for high manufacturing standards, quality products and outstanding client service.

Through our contract development and manufacturing business, Douglas CDMO, we offer our expertise, unwavering attention, dedication, and leading technology. We partner with biotechnology and pharmaceutical companies to successfully bring their products to life and out to market. Learn more at www.douglascdmo.com.

At Douglas, our mission is to improve lives. We’re proud of our world class research, our products and our technology. Our talented team works with innovative partners to research and develop, manufacture, market and distribute pharmaceutical and nutraceutical products around the world. We also supply automated dispensing machines to New Zealand pharmacies as well as manufacture and distribute a range of consumer healthcare products.

Every day, close to 700 people innovate, collaborate, and grow with a company that puts people first, while supporting and challenging them to do their life’s best work.

Specialties

All 8 specialties
  • CMO
  • CDMO
  • Pharmaceutical jobs
  • R&D
  • QC
  • Pharma
  • Clinicians
  • Scientist

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary NZ. Codes: NZ.1 countryprimary NZNZ
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryNZ

All codes: NZ

Addresses

  • NZ2 Te Pai Place; Auckland, AUK 0610Primary

Grid intelligence Members

Funding

Last round · 24 September 2023US$ 76.4KGrant · investor: Callaghan Innovation
Rounds4
Round typeGrant · non-equity funding
Amount (USD)76,400
Stage rank1
Investors named1
Since last round2 yr 3 mo

Funding

4 funding roundsFunding timeline. Latest round 24 Sep 2023: Grant, US$ 76.4K.19672026GrantUS$ 76.4K4 rounds
Show as table · 4 funding rounds
4 funding rounds
Rounds4
Axis1967 to 2026
Grant · 24 Sep 2023US$ 76.4K

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at Douglas Pharmaceuticals?

The record holds 616 counted staff profiles at January 2026, inside the self-reported 501–1,000 band.

Where does Douglas Pharmaceuticals have offices?

One address on record, New Zealand only. Primary: 2 Te Pai Place, Auckland, AUK 0610.

Has Douglas Pharmaceuticals raised funding?

Four rounds. Latest 24 September 2023: grant, US$76,400, investor Callaghan Innovation.

What does Douglas Pharmaceuticals list as its specialties?

Eight tags on the brand's own list, among them r&d and pharma.

Which companies are listed alongside Douglas Pharmaceuticals?

94 profiles list Douglas Pharmaceuticals as a peer — 99th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Vitex Pharmaceuticals Pty Ltd and Argenta list it back.

What is Douglas Pharmaceuticals's website?